DCI
PACB icon

Data Collective II’s Pacific Biosciences PACB Stock Holding History

Data Collective II’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$953K Hold
164,249
– – 11.29% 2
2022
Q2 		$726K Hold
164,249
– – 3.57% 3
2022
Q1 		$1.5M Hold
164,249
– – 5.44% 3
2021
Q4 		$3.36M Buy
+164,249
New +$3.96M 3.5% 4

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Data Collective II's PACB Position: Q3 2022 in Review

Data Collective II held its Pacific Biosciences (PACB) position steady in Q3 2022 at 164,249 shares worth $953K. The position accounts for 11.29% of the portfolio, ranked #2.

Data Collective II first reported a position in PACB in Q4 2021 and has held it in 4 quarters since. The position peaked at $3.36M in Q4 2021. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2022.

  • Data Collective II held 164,249 shares of Pacific Biosciences worth $953K as of Q3 2022.
  • Data Collective II left its Pacific Biosciences share count unchanged in Q3 2022.
  • Pacific Biosciences made up 11.29% of Data Collective II's portfolio in Q3 2022, its #2 holding.
  • Data Collective II first reported a position in Pacific Biosciences in Q4 2021 and has held it in 4 quarters since.
  • Data Collective II's Pacific Biosciences position peaked at $3.36M in Q4 2021.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2022.

Based on Data Collective II's 13F filing for Q3 2022, filed 14 Nov 2022.